Skip to main content
. 2017 Oct 16;131(1):84–94. doi: 10.1182/blood-2017-04-773838

Table 4.

Univariate Cox proportional hazards model for predicting event-free survival

Potential prognostic factor HR (lower limit-upper limit) P
Categorical variables
 Sex
  Female vs male 0.84 (0.3941-1.7839) .6473
 Consolidation RT
  No vs yes 4.71 (1.3281-16.6805) .0164
 GHSG classification
  IIB-advanced vs early-favorable 7.56 (1.6917-33.7941) .0081
  Early-unfavorable vs early-favorable 2.89 (0.8589-9.7276) .0865
 Ann Arbor disease stage
  I vs II 0.19 (0.0260-1.4101) .1046
 B-symptoms
  No vs yes 0.53 (0.2418-1.1540) .1095
 Bulky disease
  No vs yes 0.53 (0.2447-1.1361) .1022
 Extranodal disease
  No vs yes 1.31 (0.1774-9.6295) .7927
 Chemotherapy regimen
  ABVD vs other 0.93 (0.2792-3.0789) .9017
Continuous variables
 Age at diagnosis 1.01 (0.9823-1.0305) .6174
 ESR 0.99 (0.9763-1.0242) .9966
 Radiation dose 1.32 (1.0929-1.5910) .0039
 Total MTVst 1.00 (1.0006-1.0019) .0002
 Total TLGst 1.00 (1.0001-1.0004) .0004
 Total MTVt 1.00 (1.0007-1.0025) .0004
 Total MTVt 100-unit increase 1.17 (1.0735-1.2793) .0004
 Total TLGt 1.00 (1.0001-1.0004) .0011
 Total TLGt 500-unit increase 1.13 (1.0514-1.2228) .0011
 Longest axial diameter of disease 1.17 (1.0139-1.3604) .0320
 Longest sagittal diameter of disease 1.11 (1.0013-1.2341) .0471
 Longest coronal diameter of disease 1.17 (1.0618-1.2872) .0015
 Maximum SUV 1.02 (0.9633-1.0781) .5100